Depression
Series: Primer On Series;
- Publisher's listprice GBP 92.00
-
43 953 Ft (41 860 Ft + 5% VAT)
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 10% (cc. 4 395 Ft off)
- Discounted price 39 558 Ft (37 674 Ft + 5% VAT)
Subcribe now and take benefit of a favourable price.
Subscribe
43 953 Ft
Availability
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Publisher OUP USA
- Date of Publication 6 December 2019
- ISBN 9780190929565
- Binding Paperback
- No. of pages520 pages
- Size 178x251x27 mm
- Weight 907 g
- Language English 18
Categories
Short description:
This book provides an introduction to depression, including common comorbid conditions and differential diagnoses, treatment strategies, and considerations in special populations.
MoreLong description:
Major depressive disorder (MDD) is a serious, debilitating, life-shortening illness that affects many persons of all ages and backgrounds. The lifetime risk for MDD is 7-12% for men and 20-25% for women (Kessler et al., 2003). MDD is a disabling disorder that costs the U.S. over $200 billion per year in direct and indirect costs (Greenberg et al., 2015), and is the leading cause of disability worldwide (WHO, 2018). Depression also has detrimental effects on all aspects of social functioning (e.g., self-care, social role, and family life, including household, marital, kinship, and parental roles). While there have been several treatments that are efficacious, many individuals suffering from depression experience life-long challenges due to the chronic and episodic nature of the disease. Identifying strategies to find the right treatments for the right patients is critical. Ongoing research has explored the importance of examining physiologic biomarkers, as well as clinical characteristics to gain a better understanding of subtypes of depression, which will lead to improved treatments and better outcomes.
This book provides an introduction to the etiology and pathophysiology of depression, common comorbidities and differential diagnoses, pharmacotherapy strategies, psychotherapeutic and neuromodulation interventions, novel and non-traditional treatment strategies, and considerations in special populations.
Table of Contents:
1.Introduction and Overview
I. Etiology/Pathophysiology
2. Neurobiology
3. Genetic Risk Factors
4. Environmental and Social Risk Factors
5. Blood-based Biomarkers
II. Comorbidities and Differential Diagnoses
6. Anxiety Disorders
7. Bipolar Disorder
8. Suicidality
9. General Medical Conditions
10. General Medical Conditions, Metabolic Disorders
III. Pharmacotherapy for Depression
11. First line and combination therapeutics
12. Augmentation strategies
13. Rapid-acting antidepressants
14. Side Effects of Antidepressant
15. Strategies for targeting residual symptoms
IV. Psychotherapy and modalities of delivery for Depression
16. Cognitive Behavioral Therapy/Behavioral Activation
17. Behavioral Activation for Depression
18. Psychodynamic and Supportive Psychotherapy
19. ECT/TMS
V. Novel, Non-Traditional Treatment Strategies for Depression
20. Exercise as a treatment for depression
21. Therapeutic Mindfulness For Relapse Prophylaxis in Unipolar Depression
22. Probiotics and Neutraceuticals
23. Chronobiological Treatments: Sleep and Light Therapies
VI. Special Populations in Depression
24. Children and Adolescents
25. Elderly Patients
26. Pregnant and Postpartum
27. Depression Following Mild Traumatic Brain Injury
28. Treatment in Primary Care
VII. MISCELLANEOUS
29. Future Directions: Precision Medicine and Biosignatures
